Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

被引:238
作者
Smith, MR
Wilson, ML
Hamanaka, R
Chase, D
Kung, HF
Longo, DL
Ferris, DK
机构
[1] UNIV CALIF SAN DIEGO,GRAD PROGRAM BIOMED SCI,SAN DIEGO,CA 92093
[2] OITA MED UNIV,DEPT BIOCHEM,OITA 8791706,JAPAN
[3] NCI,FREDERICK CANC RES & DEV CTR,NIA,FREDERICK,MD 21702
[4] NCI,FREDERICK CANC RES & DEV CTR,LAB BIOCHEM PHYSIOL,DIV BASIC SCI,FREDERICK,MD 21702
[5] NIA,NIH,BALTIMORE,MD 21224
关键词
D O I
10.1006/bbrc.1997.6633
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinase (Plk) is the mammalian homologue of the Drosophila polo and Saccharomyces cerevisiae CDC5 genes, which are thought to be involved in regulating chromosomal segregation. Previously, we showed that transient ectopic expression of Plk could induce DNA synthesis in quiescent NIH 3T3 cells, suggesting that Plk might also have a function during G(1) or S phase, Here we report that microinjection of Plk mRNA is sufficient to drive quiescent cells into mitosis and that constitutive expression of Plk in NIH 3T3 cells causes oncogenic focus formation. These transformed cells grow in soft agar and form tumors in nude mice. Because Plk expression has been shown to be high in various human tumors, we suggest that Plk may contribute to the promotion and/or progression of human cancers. (C) 1997 Academic Press.
引用
收藏
页码:397 / 405
页数:9
相关论文
共 39 条
[11]   POLO-LIKE KINASE IS A CELL-CYCLE-REGULATED KINASE ACTIVATED DURING MITOSIS [J].
HAMANAKA, R ;
SMITH, MR ;
OCONNOR, PM ;
MALOID, S ;
MIHALIC, K ;
SPIVAK, JL ;
LONGO, DL ;
FERRIS, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21086-21091
[12]  
HAMANAKA R, 1994, CELL GROWTH DIFFER, V5, P249
[13]  
Hardy CFJ, 1996, MOL CELL BIOL, V16, P6775
[14]   Prostaglandin A(2) blocks the activation of G(1) phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation [J].
Hitomi, M ;
Shu, JY ;
Strom, D ;
Hiebert, SW ;
Harter, ML ;
Stacey, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9376-9383
[15]   ACTIVATION OF THE PHOSPHATASE-ACTIVITY OF HUMAN CDC25A BY A CDK2 CYCLIN-E DEPENDENT PHOSPHORYLATION AT THE G(1)/S TRANSITION [J].
HOFFMANN, I ;
DRAETTA, G ;
KARSENTI, E .
EMBO JOURNAL, 1994, 13 (18) :4302-4310
[16]   INDUCTION AND DOWN-REGULATION OF PLK, A HUMAN SERINE/THREONINE KINASE EXPRESSED IN PROLIFERATING CELLS AND TUMORS [J].
HOLTRICH, U ;
WOLF, G ;
BRAUNINGER, A ;
KARN, T ;
BOHME, B ;
RUBSAMENWAIGMANN, H ;
STREBHARDT, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1736-1740
[17]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[18]   CDC25A IS A NOVEL PHOSPHATASE FUNCTIONING EARLY IN THE CELL-CYCLE [J].
JINNO, S ;
SUTO, K ;
NAGATA, A ;
IGARASHI, M ;
KANAOKA, Y ;
NOJIMA, H ;
OKAYAMA, H .
EMBO JOURNAL, 1994, 13 (07) :1549-1556
[19]  
KAMAGAI A, 1996, SCIENCE, V273, P1377
[20]   P53, CELL-CYCLE CONTROL AND APOPTOSIS - IMPLICATIONS FOR CANCER [J].
KASTAN, MB ;
CANMAN, CE ;
LEONARD, CJ .
CANCER AND METASTASIS REVIEWS, 1995, 14 (01) :3-15